Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Leukemia Cooperative Groups

The most effective post-remission treatment to maintain complete remission (CR) in adults aged between 46 and 60 years with acute myeloid leukaemia (AML) is uncertain. Previously untreated patients with AML in CR after induction chemotherapy with daunorubicin and cytarabine were randomized between t...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hengeveld, Marysia, Suciu, Stefan, Karrasch, Matthias, Specchia, Giorgina, Marie, Jean-Pierre, Muus, Petra, Petti, Maria C., Rotoli, Bruno, Amadori, Sergio, Fioritoni, Guiseppe, Leoni, Pietro, Morra, Enrica, Thaler, Joseph, Resegotti, Luigi, Fazi, Paola, Vignetti, Marco, Mandelli, Franco, Zittoun, Robert, de Witte, Theo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345117/ https://www.ncbi.nlm.nih.gov/pubmed/22460947 http://dx.doi.org/10.1007/s00277-012-1436-z